Brokerages expect that Alteryx Inc (NYSE:AYX) will report $35.86 million in sales for the current fiscal quarter, according to Zacks. Four analysts have issued estimates for Alteryx’s earnings, with the highest sales estimate coming in at $36.00 million and the lowest estimate coming in at $35.80 million. The firm is expected to report its next quarterly earnings report after the market closes on Wednesday, February 21st.
According to Zacks, analysts expect that Alteryx will report full-year sales of $35.86 million for the current year, with estimates ranging from $128.80 million to $129.01 million. For the next financial year, analysts forecast that the company will report sales of $174.76 million per share, with estimates ranging from $168.70 million to $178.20 million. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that follow Alteryx.
Alteryx (NYSE:AYX) last issued its quarterly earnings data on Thursday, November 9th. The company reported $0.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.10. Alteryx had a negative net margin of 18.68% and a negative return on equity of 19.62%. The firm had revenue of $34.16 million during the quarter, compared to the consensus estimate of $32.06 million. During the same quarter in the previous year, the firm posted ($0.07) EPS. The company’s revenue for the quarter was up 52.1% compared to the same quarter last year.
Shares of Alteryx (NYSE AYX) opened at $25.54 on Monday. Alteryx has a 1 year low of $14.61 and a 1 year high of $31.60.
In related news, CEO Dean Stoecker sold 20,000 shares of the company’s stock in a transaction on Thursday, December 28th. The shares were sold at an average price of $25.87, for a total value of $517,400.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, major shareholder Qualified Master Fund L. Abdiel bought 75,000 shares of the company’s stock in a transaction that occurred on Tuesday, December 5th. The stock was purchased at an average cost of $25.54 per share, with a total value of $1,915,500.00. The disclosure for this purchase can be found here. Insiders sold a total of 241,470 shares of company stock valued at $6,306,932 in the last ninety days.
Hedge funds have recently made changes to their positions in the business. Nationwide Fund Advisors purchased a new stake in Alteryx in the 2nd quarter worth $100,000. The Manufacturers Life Insurance Company lifted its stake in Alteryx by 685.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 7,853 shares of the company’s stock worth $154,000 after purchasing an additional 6,853 shares in the last quarter. New York State Common Retirement Fund purchased a new stake in Alteryx in the 2nd quarter worth $187,000. Invictus RG purchased a new stake in Alteryx in the 3rd quarter worth $202,000. Finally, Rhumbline Advisers purchased a new stake in Alteryx in the 2nd quarter worth $195,000. Institutional investors and hedge funds own 28.21% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Zacks: Analysts Expect Alteryx Inc (AYX) Will Post Quarterly Sales of $35.86 Million” was published by American Banking News and is owned by of American Banking News. If you are viewing this story on another website, it was illegally copied and republished in violation of US & international copyright and trademark laws. The original version of this story can be read at https://www.americanbankingnews.com/2018/02/12/zacks-analysts-expect-alteryx-inc-ayx-will-post-quarterly-sales-of-35-86-million.html.
Alteryx Company Profile
Alteryx, Inc is a United States-based provider of self-service data analytics software. The Company offers various products, such as Alteryx Designer, Alteryx Server and Alteryx Analytics Gallery. Alteryx Designer is a repeatable workflow for self-service data analytics. Alteryx Designer allows data analysts by combining data preparation, data blending, and analytics-predictive, statistical and spatial-using the same user interface.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Alteryx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alteryx and related companies with MarketBeat.com's FREE daily email newsletter.